Research also suggests that the effects of cardiometabolic health can be affected following discontinuation of semaglutide use, which can increase risk factors for obesity related diseases such as diabetes and hypertension
Nutrition journal , 15 , 1-7
That is legal and not uncommon in clinical practice, but it is worth understanding before you start asking your provider about it
Contact your healthcare provider if you experience weight regain of approximately 3-5% of your body weight within a few weeks, return of obesity-related complications such as uncontrolled blood pressure or worsening diabetes control, severe increase in appetite interfering with daily functioning, or psychological distress related to weight changes
Yet, what was lost in the narrative is that perhaps as many as 10k, or 100k or even more people have gotten retatrutide from the compounders